Storing semaglutide at room temperature or above accelerates chemical degradation, reducing its weight loss effectiveness and potentially compromising safety
When to Speak to a Doctor or Specialist Clinician Anyone considering these agents should seek medical advice before use
Intestinal obstruction : Rare cases of ileus have been reported
A large UK study has found that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may raise the risk of gastroesophageal reflux disease (GERD) and related complications
Commonly reported outcomes that are mild in nature include the following: Nausea Vomiting Diarrhea Abdominal pain Constipation Headache Fatigue Dizziness Injection site reactions (such as redness, swelling, or itching) Decreased appetite In addition to the above, there is also the possibility of adverse effects, including: Pancreatitis Hypoglycemia Kidney problems Gallbladder problems Allergic reactions Retinopathy Acute renal failure Severe hypersensitivity reactions Possible drug interactions In addition to undesirable outcomes, the drug may also interact with other medications, supplements, and foods, with an impact on effectiveness and may also increase the risk of side effects
